NL-OMON37821已完成不适用
Evaluation of Continuous Glucose Monitoring as a Tool to Measure Glucoregulatory Effects of a Twice Daily Oral Insulin Secretagogue - CGM main Study
PRA International EDS0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients diagnosed with DM Type 2
- •18-79 years, inclusive
- •BMI 23-38 kg/m2 inclusive
- •non smoker or smoke less than 5 cigarettes
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters (males) or 1.0 liters (females) of blood in the 10 months prior the start of this study. Participation is also not permitted when participated in more than 3 other drug studies in the 10 months prior to the start of this study.
研究者
相似试验
尚未招募
不适用
ECSPECT-HYPO trialNL-OMON29063Vrije Universiteit Medical Center115
已完成
不适用
Effectiveness of Continuous Glucose Monitoring versus Stepped Care with HypoAware, a Web-Based PsychoEducational Intervention, and adding CGM as needed, in Adult Type 1 Diabetes with Impaired Hypoglycemia Awareness: ECSPECT-HYPO trialNL-OMON48870Vrije Universiteit Medisch Centrum124
尚未招募
4 期
Role of continuous glucose monitoring device on diabetes patientCTRI/2024/02/062647Dr.Priyamadhabha Behera
已完成
不适用
Effectiveness of continuous glucose monitoring during diabetic pregnancydiabetes mellitusNL-OMON38017Academisch Medisch Centrum300
尚未招募
2 期
To evaluate whether personalized dietary and physical activity advice based on CGMS data would be effective in preventing the occurrence of gestational diabetes mellitus in high risk women.CTRI/2024/07/071323Dr Yashdeep Gupta